Browse 43 Health Care companies funded by Novo Holdings. See funding amounts, founder contacts, and investment details.
Tempus develops AI-enabled precision medicine technology that supports clinical decision-making and biomedical research.
Mirum Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of therapies.
Route 92 Medical is a medical device company developing a catheter to treat stroke.
CoultreonBiopharma is developing best-in-class therapeutics that target clinically validated pathways in immunology and metabolic illnesses.
Ray Therapeutics is a biotech company that develops optogenetic gene therapies for patients with blinding diseases.
Spruce Biosciences is a biopharmaceutical company developing therapies for rare diseases that target the endocrine system.
Adcendo is a biotech company that develops antibody-drug conjugates (ADCs) to target cancers with high unmet medical needs.
Expedition Therapeutics is a biotechnology company that develops novel therapies for inflammatory and respiratory diseases.
Nalu Medical is a medical technology company that offers neurostimulation system designed to treat chronic nerve pain.
GlycoEra is a biotechnology research company that produces extracellular protein degraders for the treatment of autoimmune diseases.
HepaRegeniX is developing drugs for treating acute and chronic liver diseases.
Callio Therapeutics develops next-generation, multi-payload antibody-drug conjugates (ADCs).
Numab is a biotechnology company that offers antibody-based therapeutics for the treatment of severe diseases.
Orbis Medicines is a novel macrocyclic chemistry and computational platform for oral macrocycle drug discovery.
Nuvig Therapeutics is a biotechnology company developing therapies to induce natural mechanisms to restore immune homeostasis.
Convergent Therapeutics is a pharmaceutical company that focuses on developing radiopharmaceutical therapies for prostate cancer.
Draupnir Bio is developing a new type of cholesterol-lowering medicine which prevents blood clots in the heart.
Bluejay Therapeutics is a private biopharmaceutical company focused on the development of cures for infectious diseases.
Octave provides mental health care that's both accessible to people and sustainable for providers.
Hoba Therapeutics is developing a new therapeutic protein for the treatment of neuropathic pain.
Doctor Anywhere is a telehealth company .
Minervax is a biotechnology company developing a novel vaccine against Group B Streptococcus.
Clever Care Health Plan is a healthcare company that offers medicare advantage health plans to its members.
Centauri Therapeutics is a UK-based biotechnology company focused on the discovery and development of life threatening diseases.
Bactolife is a biotechnology company that develops biological solutions to support gut health.
Praxis develops therapies for CNS disorders by leveraging genetic insights into neuronal imbalances, targeting rare to common conditions.
Sidera Bio harness human genetics, that helps in transformative medicines for patients.
Cogent Biosciences is a biotechnology company that develops therapies for solid cancer tumors.
Cleveland Diagnostics is a diagnostics company developing efficacious, affordable diagnostics tests to improve cancer diagnostics.
Crystalys Therapeutics is a clinical-stage biopharmaceutical company transforming the treatment of gout.
KalVista Pharmaceuticals is an ophthalmology company focused on developing drugs for the treatment of diabetic macular edema (DME).
Mission Bio develops only single-cell multi-omics platform integrating genotype and phenotype for cancer research and biomarker development.
MedGenome develops a genomics-based diagnostics and research solution for healthcare providers to understand the genetic basis of diseases.
Based on our deep science and focused on patients in need.
Supira Medical is a clinical-stage company that develops catheter-based circulatory support devices for patients with heart conditions.
Hillstar Bio is developing precision immunotherapies to treat autoimmune diseases.
Claris Biotherapeutics develops a topical formulation intended to cure corneal wounds, ulcers, and scars.
FIRE1 and is based in Dublin, Ireland, will focus on developing novel therapeutic devices.
Harmony Biosciences is a pharmaceutical company that develops and commercializes novel therapies for rare neurological disorders.
Kivu Bioscience is a biotechnology company that focuses on developing next-generation antibody-drug conjugates to target cancer.
Magenta Medical is engaged in the development of novel device solutions for the treatment of acute and chronic heart failure.
Exscientia is a pharmatech company that uses an end-to-end AI platform to design and discover new drugs.
Arcellx develops engineered cell-based immunotherapies for the treatment of cancer and other serious diseases.
View all companies funded by Novo Holdings across every industry and funding stage.
View Full Novo Holdings Portfolio